Global Neurovascular Stents Market - 2025-2033

The global neurovascular stents market reached US$ 1,251.75 million in 2024 and is expected to reach US$ 3,040.53 million by 2033, growing at a CAGR of 10.4% during the forecast period 2025-2033.

Neurovascular stents are small, mesh-like tubular devices implanted within brain blood vessels to treat various neurovascular conditions. They help restore normal blood flow by reinforcing weakened or narrowed arteries, reducing the risk of strokes and aneurysm ruptures. These stents come in different types, including intracranial stents for opening blocked brain arteries, flow diverters for large or wide-necked aneurysms, stent retrievers for removing blood clots in acute ischemic stroke, and carotid stents for preventing strokes caused by carotid artery stenosis.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Neurovascular Disorders

The rising prevalence of neurovascular disorders, such as stroke, aneurysms, and carotid artery disease, is significantly driving the growth of the neurovascular stents market. As the global population ages, the incidence of these conditions is increasing, particularly among older adults who are more vulnerable to cerebrovascular diseases.

The growing burden of ischemic strokes, which occur when blood flow to the brain is blocked, has led to a higher demand for neurovascular stents as a treatment option to restore blood flow and prevent further damage. For instance, according to a report by the National Institute of Health in 2025, it is stated that researchers estimate that approximately 795,000 people in the United States experience a stroke, with around 610,000 being first-time occurrences. Nearly 1 in 4 stroke survivors will suffer another stroke in their lifetime. Ischemic strokes, which occur due to blocked blood flow to the brain, account for about 87% of all stroke cases. Intracranial rescue stenting (RS) is an option for acute ischemic stroke after the failure of mechanical thrombectomy (MT). This increasing number of individuals with ischemic stroke individuals increases the need for neurovascular stenting procedures.

Additionally, the increasing number of patients suffering from intracranial atherosclerosis and intracranial aneurysms is fueling the adoption of stents designed to strengthen weakened blood vessels and reduce the risk of rupture.

High Cost of Neurovascular Stent Procedures

The high cost of neurovascular stent procedures is a significant barrier to market growth, particularly in developing regions where healthcare budgets and insurance coverage are limited. Neurovascular stents, along with the required imaging, surgical expertise, and post-procedure care, make the overall treatment expensive and the cost of the procedures varies depending on the complexity and location.

Segment Analysis

The global neurovascular stents market is segmented based on the type, material, application, end-user, and region.

Intracranial stents in the type segment is expected to dominate the neurovascular stents market

The intracranial stent segment is expected to dominate the global neurovascular stents market due to the rising incidence of ischemic strokes, intracranial atherosclerosis, and wide-necked aneurysms. As more patients suffer from cerebrovascular diseases, the demand for minimally invasive stenting solutions continues to grow. Intracranial stents provide a lifesaving alternative to traditional open surgeries, reducing recovery time and improving patient outcomes.

Technological advancements, such as drug-eluting and bioresorbable stents, are also driving adoption, as they help prevent complications like restenosis. Rising number of launches across various regions is expected to drive the segment's growth as these stents will be available for a vast range of individuals. For instance, in June 2024, MicroVention, Inc. announced the commercial launch of the LVIS EVO Intraluminal Support Device in the United States for the treatment of wide-neck intracranial aneurysms. The LVIS EVO, which has been available in Europe since 2019, has already seen over 12,000 units sold. Notably, it is the first fully visible coil-assist intracranial stent introduced to the U.S. market, marking a significant advancement in neurovascular treatment. Additionally, the aging global population is contributing to increased demand, as older adults are more susceptible to neurovascular conditions requiring stent placement.

Geographical Analysis

North America is expected to dominate the neurovascular stents market

North America is expected to dominate the global neurovascular stents market due to several key factors. The region has a high prevalence of neurovascular diseases, including stroke, aneurysms, and intracranial atherosclerosis, driving demand for advanced treatment options like neurovascular stents. For instance, according to the Brain Aneurysm Foundation, with approximately 1 in 50 people in the United States affected by brain aneurysms and an estimated 6.7 million Americans living with an unruptured aneurysm, the demand for neurovascular stents continues to rise, as around 30,000 individuals suffer a rupture each year, increasing the need for advanced neurovascular interventions to prevent life-threatening complications and driving the neurovascular stents market in North America.

The aging population further contributes to this demand, as older adults are at a higher risk of cerebrovascular conditions. The presence of leading medical device companies ensures continuous innovation and a strong pipeline of technologically advanced stents, including drug-eluting and bioresorbable stents. Additionally, well-established healthcare infrastructure, including specialized neurology centers and stroke care units, supports faster adoption of neurovascular stents in hospitals and clinics.

Competitive Landscape

The global market players in the neurovascular stents market are Stryker, Acandis GmbH, Balt Group, Boston Scientific Corporation, Terumo Corporation and MicroPort Scientific Corporation among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming pharmaceutical advancements.
• Type Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Type delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global neurovascular stents market report would provide approximately 45 tables, 46 figures, and 180 pages.

Target Audience 2024

• Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.